ArticleInternational journal of impotence research2026
Nonlinear association between vitamin D levels and response to tadalafil 5 mg daily treatment in erectile dysfunction patients: a prospective cohort study.
Article in International journal of impotence research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Erectile dysfunction (ED) is a common male sexual disorder. Vitamin D (VD) deficiency is frequent in ED patients and has been associated with greater disease severity, but its role in predicting treatment response remains unclear. In this prospective cohort study, 202 ED patients were initially enrolled, and after excluding 30 ineligible cases, 172 were included in the final analysis at Chengdu University of TCM Affiliated Hospital (September 2023-August 2024). ED severity was evaluated using the International Index of Erectile Function-5 (IIEF-5) during a 1-month follow-up, with 152 patients (88.4%) reporting symptomatic improvement after daily tadalafil 5 mg treatment. Patients with VD ≥ 20 ng/mL showed faster responses. Multivariate Cox regression demonstrated a significant positive association between baseline VD levels and treatment outcomes (adjusted hazard ratio = 1.60 per 1 ng/mL increase; 95% confidence interval: 1.31-1.95). Restricted Cubic Spline analysis revealed a nonlinear relationship, with the strongest effect observed at VD ≤ 19.6 ng/mL, representing a data-driven inflection point. Interaction analyses further confirmed consistent benefits across all age groups. These findings indicate that baseline VD is an independent prognostic factor for tadalafil efficacy in ED, highlighting its potential clinical utility for risk stratification and individualized treatment decisions in ED.
Identifiers
41699327What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.